Literature DB >> 14996963

Intracerebral haemorrhage, prosthetic heart valve and anticoagulation.

N Shah1, S L Dawson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14996963      PMCID: PMC1079326          DOI: 10.1177/014107680409700311

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  5 in total

1.  Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding.

Authors:  G Evans; R Luddington; T Baglin
Journal:  Br J Haematol       Date:  2001-12       Impact factor: 6.998

2.  Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients.

Authors:  F E Preston; S T Laidlaw; B Sampson; S Kitchen
Journal:  Br J Haematol       Date:  2002-03       Impact factor: 6.998

3.  How safely and for how long can warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage?

Authors:  K Ananthasubramaniam; J N Beattie; H S Rosman; V Jayam; S Borzak
Journal:  Chest       Date:  2001-02       Impact factor: 9.410

Review 4.  Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.

Authors:  S C Cannegieter; F R Rosendaal; E Briët
Journal:  Circulation       Date:  1994-02       Impact factor: 29.690

5.  Optimal oral anticoagulant therapy in patients with mechanical heart valves.

Authors:  S C Cannegieter; F R Rosendaal; A R Wintzen; F J van der Meer; J P Vandenbroucke; E Briët
Journal:  N Engl J Med       Date:  1995-07-06       Impact factor: 91.245

  5 in total
  2 in total

1.  Dilemmas in managing intracerebral haemorrhage and thromboembolism.

Authors:  Joanna Chikwe; Lauren Ovens
Journal:  J R Soc Med       Date:  2004-06       Impact factor: 18.000

2.  Dilemmas in managing intracerebral haemorrhage and thromboembolism.

Authors:  R Fuller; N J Dudley; J Maule; T Stewart
Journal:  J R Soc Med       Date:  2004-06       Impact factor: 18.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.